মূল্য
দামগুলো আনুমানিক MRP এবং ফার্মেসিভেদে ভিন্ন হতে পারে। সর্বশেষ নথিভুক্ত দামের সাথে তুলনা করে ট্রেন্ড দেখানো হয়।
সব দামের পরিবর্তন →Dizuva
Rx1 mg+100 mg • ক্যাপসুল
ইঙ্গিত ও ব্যবহার
Dizuva capsule is indicated for use during continuous combined Hormone Replacement Therapy (HRT) for estrogen deficiency symptoms in postmenopausal women with an intact uterus and with at least 12 months since last menses.
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
প্রাপ্তবয়স্ক:
Adult: Take a single capsule orally each evening with food.Pediatrics: This capsule has not been studied in this patient population and is not recommended for use.Geriatrics: This capsule has not been studied in this patient population and is not recommended for use.Hepatic Insufficiency: This capsule is contraindicated in women with liver dysfunction or disease as long as liver function tests have failed to return to normal.Renal Insufficiency: This capsule is to be used with caution in women with renal dysfunction.
পার্শ্বপ্রতিক্রিয়া
Common: Alopecia, nausea, abdominal pain, headache, fatigue, flatulence, dizziness, vaginal hemorrhage, vaginal discharge, uterine spasm, pelvic pain and breast pain.Rare: Ear swelling, vertigo, hirsutism, dry eye, vision blurred, visual impairment, vitreous floaters, cholelithiasis, unstable angina.
সতর্কতা ও নিষেধাজ্ঞা
সতর্কতা ও সাবধানতা
Women using HRT sometimes experience increased blood pressure. Blood pressure should be monitored with HRT use. Elevation of blood pressure in previously normotensive or hypertensive patients should be investigated and HRT may have to be discontinued. Estrogens with or without progestins may cause fluid retention. Therefore, particular caution is indicated in cardiac or renal dysfunction or asthma.Patients who develop visual disturbances, classical migraine, transient aphasia, paralysis or loss of consciousness should discontinue medication.
নিষেধাজ্ঞা
Hypersensitivity to this drug or to any ingredient in the formulation, including any non-medicinal ingredient or component of the container, patients with liver dysfunction or disease where liver function tests have failed to return to normal, history of estrogen-dependent or progestogen dependent malignant neoplasia, patients with endometrial hyperplasia, undiagnosed abnormal genital bleeding, pregnancy, breastfeeding, history of arterial thromboembolic disease, patients with classical migraine